Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine

This publication has 29 references indexed in Scilit:

• Vaxfectin™ enhances immunogenicity and protective efficacy of P. yoelii circumsporozoite DNA vaccines
  Vaccine, 2006
• I. Poloxamer-Formulated Plasmid DNA-Based Human Cytomegalovirus Vaccine: Evaluation of Plasmid DNA Biodistribution/Persistence and Integration
  Human Gene Therapy, 2005
• Neuropathogenesis in cytomegalovirus infection: indication of the mechanisms using mouse models
  Reviews in Medical Virology, 2005
• Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine
  Biochemical and Biophysical Research Communications, 2004
• Molecular, Biological, and In Vivo Characterization of the Guinea Pig Cytomegalovirus (CMV) Homologs of the Human CMV Matrix Proteins pp71 (UL82) and pp65 (UL83)
  Journal of Virology, 2004
• Identification of essential and non-essential genes of the guinea pig cytomegalovirus (GPCMV) genome via transposome mutagenesis of an infectious BAC clone
  Virus Research, 2004
• Protection against Congenital Cytomegalovirus Infection and Disease in Guinea Pigs, Conferred by a Purified Recombinant Glycoprotein B Vaccine
  The Journal of Infectious Diseases, 2004
• Preconception Vaccination with a Glycoprotein B (gB) DNA Vaccine Protects against Cytomegalovirus (CMV) Transmission in the Guinea Pig Model of Congenital CMV Infection
  The Journal of Infectious Diseases, 2003
• Vaccination of Mice with Bacteria Carrying a Cloned Herpesvirus Genome Reconstituted In Vivo
  Journal of Virology, 2003
• Molecular Cloning of the Guinea Pig Cytomegalovirus (GPCMV) Genome as an Infectious Bacterial Artificial Chromosome (BAC) in Escherichia coli
  Molecular Genetics and Metabolism, 2001